GlaxoSmithKline has forged an alliance with two leading CRISPR researchers that will see the creation of a new genomics research lab at the University of California.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh